Some individuals may require more frequent injections, while others might benefit from less frequent doses
Medical nutrition therapy remains an important component of diabetes management for patients using medications like tirzepatide, as emphasized in the American Diabetes Association Standards of Care
Novo Nordisk is planning a higher-dose version (CagriSema 2.4/7.2 mg, pairing standard cagrilintide with Wegovy HD-level semaglutide) in a new Phase 3 trial starting H2 2026
16-week cycle: 1 vial Concentration: ~3.33 mg/mL Dose basis: total blend, once weekly Insulin Syringes (U-100, 1 mL) Per injection: 1 syringe 16 weeks (once weekly): ~16 syringes Use a U-100 1 mL syringe per injection Bacteriostatic Water (10 mL bottles) Use ~3.0 mL to reconstitute the single 10 mg blend vial
Importantly, persistently high serum B12 in the absence of supplementation should prompt GP assessment, as it may indicate underlying disease processes
Ghafouri-Fard S, Shirvani-Farsani Z, Hussen BM, Taheri M, Samsami M